Stockreport

Fulgent Selected to Present Rapid Oral Abstract Within the Head and Neck Cancer Track Session at the 2026 ASCO Annual Meeting

Fulgent Genetics, Inc.  (FLGT) 
Last fulgent genetics, inc. earnings: 3/10 04:05 pm Check Earnings Report
US:NASDAQ Investor Relations: ir.fulgentgenetics.com
PDF EL MONTE, Calif.--(BUSINESS WIRE)--Fulgent Genetics, Inc. (NASDAQ: FLGT) (“Fulgent” or the “Company”), a technology-based company with a well-established laboratory [Read more]